A multinational research collaboration including the National Institute for Communicable Diseases (NICD) has found that exposure to air pollution alters the risk and timing of invasive disease caused by Streptococcus pneumoniae, and that this effect varies by bacterial subtype. The study, published on 14 September 2026 in Nature Microbiology, suggests that some pneumococcal strains trigger infection soon after pollution exposure while others are associated with illness weeks later.
Key findings and who is most at risk
"Air pollution leads to different risk of bacterial pneumonia, sepsis, and meningitis, depending on the subtype of bacteria a person has," the NICD reported.
The researchers—working with teams at the Wellcome Sanger Institute, the Barcelona Supercomputing Center and the NICD—analysed how environmental factors such as air pollution interact with S. pneumoniae serotypes to influence invasive pneumococcal disease (IPD). IPD refers to serious infections where the bacteria enter the lower respiratory tract or bloodstream, causing conditions such as pneumonia, bacterial sepsis and meningitis.
Important contextual figures cited in the release include:
- Almost 20% of adults globally carry S. pneumoniae in their nose and throat.
- There are currently more than 100 serotypes of S. pneumoniae.
- South Africa recorded just over 1 800 reported cases of IPD in 2022.
- In England, the UK Health Security Agency reports more than 5 000 cases of IPD each year.
Implications for public health policy and hospital planning
The study indicates that air quality improvements could reduce IPD risk, particularly among groups already known to be vulnerable: young children (particularly under five years) and older adults (over 65). The research team argues that knowing which serotypes are circulating, and how environmental conditions shape infection patterns, could help public health authorities protect those most at risk and prepare hospitals for shifting case loads.
For South Africa, where seasonal peaks in respiratory infections are common, the findings underscore the value of integrated surveillance that combines environmental monitoring with microbiological typing of circulating S. pneumoniae strains. Such integrated data could inform targeted interventions—such as timing of vaccination campaigns, public advisories during periods of poor air quality, and hospital resource planning.
| Affected group | Diseases (IPD) | Impact noted in study |
|---|---|---|
| Children (esp. under 5) | Pneumonia, meningitis, sepsis | Higher vulnerability during high pollution periods |
| Older adults (65+) | Pneumonia, sepsis, meningitis | Increased risk associated with pollution exposure and circulating strains |
What clinicians and the public should know
The NICD and collaborating institutions recommend that policymakers and clinicians consider both environmental and microbiological data when assessing risk. For the public, the study reinforces established advice: reducing exposure to air pollution where possible and seeking medical attention for respiratory symptoms, especially among children, older adults and people with underlying conditions.
This research does not change clinical guidance on an individual level; people should continue to follow national vaccination recommendations and consult a doctor or clinic rather than self-diagnose if they develop signs of severe respiratory infection. Health services should also anticipate potential variations in case timing linked to pollution and circulating serotypes.
The study adds to a growing body of evidence that environmental factors influence infectious disease dynamics. Further surveillance and research will be needed to translate these findings into actionable local policies, including air quality interventions and targeted public health messaging.
Readers with concerns about respiratory symptoms are advised to contact their local clinic or healthcare provider for assessment and care.
